TABLE 1

Patient Data and Impact on Therapy Management

Patient no.	Sex	Age (y)	Primary location	Grade	Prior therapy	No. of lesions	Change in therapy (confirmed by SITB)
1	M	60.5	Ileum	2	Surgery, octreotide	7	No
2	M	51.2	Rectum	2	Surgery, PRRT	13	No
3	M	39.7	Pancreas	2	Surgery	2	Yes (surgery)
4	F	62.7	Ileum	1	Surgery, octreotide	4	No
5	F	48.5	Ileum	2	Surgery	1	Yes (octreotide, bisphosphonates)
6	M	65.4	Pancreas	1	Surgery	0	No
7	M	46.0	Pancreas	2	Surgery, octreotide	2	No
8	M	51.2	Ileum	2	Surgery	0	No
9	F	73.2	Ileum	2	Surgery, octreotide	2	No
10	F	53.7	Colon	1	Surgery	1	Yes (octreotide, bisphosphonates)
11	F	47.7	Rectum	2	Surgery	2	Yes (surgery)
12	M	67.5	Ileum	2	Surgery, octreotide	8	No
13	M	74.4	Duodenum	2	Surgery	0	No
14	F	55.2	Appendix	1	Surgery	0	No
15	F	76.5	Jejunum	1	Surgery	3	Yes (surgery/ablative therapy)
16	F	60.4	Ileum	1	Surgery	0	No
17	M	59.6	Ileum	2	Surgery	0	No
18	M	70.9	Jejunum	1	Surgery, octreotide	2	No
19	M	54.5	Pancreas	2	Surgery	1	No
20	M	63.3	Stomach	1	Surgery	1	Yes (octreotide)
21	F	61.2	Ileum	2	Surgery, octreotide	2	No
22	F	72.5	Ileum	2	Surgery	0	No
23	M	54.0	Pancreas	2	Chemotherapy	4	No
24	M	67.7	Unknown	2	Octreotide	6	No
25	F	44.2	Appendix	2	Surgery	0	No
26	M	74.8	Duodenum	1	Surgery, octreotide	6	No
27	M	65.7	Pancreas	2	Surgery	2	Yes (surgery)
28	F	56.8	Pancreas	2	Surgery	7	Yes (chemotherapy)
29	F	52.3	Pancreas	1	Surgery	0	No
30	M	57.8	Appendix	1	Surgery	0	No
31	M	82.6	Jejunum	2	Surgery, octreotide	6	No

SITB = study-specific interdisciplinary NEN tumor board; PRRT = peptide-receptor radionuclide therapy.